A World Health Organization (WHO) researcher on Wednesday asserted that there is no evidence linking deaths to any CCP virus vaccine, after numerous European Union countries and other nations suspended usage of AstraZeneca’s vaccine amid reports of blood clots.
“There is no documented death that’s been linked to a COVID vaccine,” said Soumya Swaminathan, a WHO clinical scientist, in a news conference. “While we need to continue to be very closely monitoring this,” she added, “we do not want people to panic.”
The U.N.-backed health agency would “for the time being recommend that countries continue vaccinating with AstraZeneca,” the scientist said, adding that more updates are pending on Thursday.
Her statements follow ones made by the EU’s European Medicines Agency that the vaccine is safe, saying that “the benefits of the AstraZeneca vaccine in preventing COVID-19, with its associated risk of hospitalization and death, outweigh the risks of side effects.”
But France, Sweden, Germany, Spain, and Italy all suspended usage of the vaccine this week, joining dozens of other countries in and outside of Europe. Italian officials in the Piedmont region said Monday they would launch a criminal manslaughter investigation after 57-year-old music teacher Sandro Tognatti died hours after receiving the shot.
Teresa Angela Camelio, the Piedmont prosecutor, announced that the move “follow[s] the decision of the Piedmont region to suspend ‘momentarily’ the administration of the AstraZeneca vaccine included in batch ABV5811, pending the decisions of the judicial authority and the drug supervisory commission.”
Tognatti received the CCP virus vaccine in his hometown of Biella on March 13. His wife told news outlets that he went to bed that night with a high fever. The next day, she said, an ambulance was called for him, and he later died.
In a statement to The Epoch Times, AstraZeneca stated that “around 17 million people in the EU and UK have now received our vaccine, and the number of cases of blood clots reported in this group is lower than the hundreds of cases that would be expected among the general population.”
The Italian man’s death came just days after a 60-year-old Danish woman suffered highly “unusual symptoms” and died after receiving the vaccine, the Danish Medicines Agency reported. The woman had a low number of blood platelets and clots in small and large vessels, as well as bleeding, it said, according to a report from Reuters.
“It was an unusual course of illness around the death that made the Danish Medicines Agency react,” the agency said in a statement.